CASI Pharmaceuticals
CASI
#10853
Rank
NZ$7.36 M
Marketcap
NZ$0.36
Share price
0.00%
Change (1 day)
-84.81%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.78. In 2024 the company made an earnings per share (EPS) of NZ-$4.42 a decrease over its 2023 EPS that were of NZ-$3.49.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.655.18%
2024NZ-$4.4226.73%
2023NZ-$3.49-32.89%
2022NZ-$5.2011.9%
2021NZ-$4.65-38.44%
2020NZ-$7.55-8.96%
2019NZ-$8.2950%
2018NZ-$5.5377.78%
2017NZ-$3.115.88%
2016NZ-$2.94-22.73%
2015NZ-$3.80-76.09%
2014NZ-$15.89318.18%
2013NZ-$3.80-71.79%
2012NZ-$13.4765.96%
2011NZ-$8.12-50%
2010NZ-$16.24-18.97%
2009NZ-$20.04-63.64%
2008NZ-$55.103.57%
2007NZ-$53.20-60.56%
2006NZ-$134.9197.22%
2005NZ-$68.41-2.7%
2004NZ-$70.31-45.59%
2003NZ-$129.21-61.8%
2002NZ-$338.23-25.52%
2001NZ-$454.13-21.38%
2000NZ-$577.6413.86%
1999NZ-$507.34149.53%
1998NZ-$203.3298.15%
1997NZ-$102.6110.2%
1996NZ-$93.11